Medlive Technology Co., Ltd. (HK:2192)
:2192
Want to see HK:2192 full AI Analyst Report?
Total Valuation
Medlive Technology Co., Ltd. has a market cap or net worth of HK$6.41B. The enterprise value is HK$3.03B.
Market CapHK$6.41B
Enterprise ValueHK$3.03B
Share Statistics
Medlive Technology Co., Ltd. has 739,958,740 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding739,958,740
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Medlive Technology Co., Ltd.’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 3.21%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)3.21%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee837.40K
Profits Per Employee482.31K
Employee Count747
Asset Turnover0.12
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Medlive Technology Co., Ltd. is 19.6. Medlive Technology Co., Ltd.’s PEG ratio is 8.43.
PE Ratio19.6
PS Ratio10.21
PB Ratio1.31
Price to Fair Value1.31
Price to FCF52.49
Price to Operating Cash Flow35.95
PEG Ratio8.43
Income Statement
In the last 12 months, Medlive Technology Co., Ltd. had revenue of 625.54M and earned 325.69M in profits. Earnings per share was 0.44.
Revenue625.54M
Gross Profit360.20M
Operating Income164.72M
Pretax Income350.96M
Net Income325.69M
EBITDA185.26M
Earnings Per Share (EPS)0.44
Cash Flow
In the last 12 months, operating cash flow was 154.08M and capital expenditures -11.64M, giving a free cash flow of 142.44M billion.
Operating Cash Flow154.08M
Free Cash Flow142.44M
Free Cash Flow per Share0.19
Dividends & Yields
Medlive Technology Co., Ltd. pays an annual dividend of HK$0.128, resulting in a dividend yield of 2.72%
Dividend Per ShareHK$0.128
Dividend Yield2.72%
Payout Ratio57.16%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.31
52-Week Price Change-26.80%
50-Day Moving Average9.05
200-Day Moving Average11.55
Relative Strength Index (RSI)57.31
Average Volume (3m)1.46M
Important Dates
Medlive Technology Co., Ltd. upcoming earnings date is Sep 1, 2026, TBA (Confirmed).
Last Earnings DateMar 26, 2026
Next Earnings DateSep 1, 2026
Ex-Dividend Date―
Financial Position
Medlive Technology Co., Ltd. as a current ratio of 19.09, with Debt / Equity ratio of 0.21%
Current Ratio19.09
Quick Ratio19.09
Debt to Market Cap<0.01
Net Debt to EBITDA-13.81
Interest Coverage Ratio306.33
Taxes
In the past 12 months, Medlive Technology Co., Ltd. has paid 12.08M in taxes.
Income Tax12.08M
Effective Tax Rate0.03
Enterprise Valuation
Medlive Technology Co., Ltd. EV to EBITDA ratio is 20.67, with an EV/FCF ratio of 31.47.
EV to Sales6.12
EV to EBITDA20.67
EV to Free Cash Flow31.47
EV to Operating Cash Flow28.47
Balance Sheet
Medlive Technology Co., Ltd. has HK$3.72B in cash and marketable securities with HK$10.11M in debt, giving a net cash position of HK$3.71B billion.
Cash & Marketable SecuritiesHK$3.72B
Total DebtHK$10.11M
Net CashHK$3.71B
Net Cash Per ShareHK$5.02
Tangible Book Value Per ShareHK$6.37
Margins
Gross margin is 58.77%, with operating margin of 26.33%, and net profit margin of 52.07%.
Gross Margin58.77%
Operating Margin26.33%
Pretax Margin56.11%
Net Profit Margin52.07%
EBITDA Margin29.62%
EBIT Margin26.33%
Analyst Forecast
The average price target for Medlive Technology Co., Ltd. is HK$13.10, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetHK$13.10
Price Target Upside33.27% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast15.04%
EPS Growth Forecast5.57%